logo

For the Inventor, By the Inventor

Yokohama, Japan

Takashi Hisamatsu

This inventor holds 7 USPTO granted patents. Top assignees: Meiji Seika Kaisha, Ltd., Other. Active years: 1978-1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Hisamatsu. Retrieved from https://idiyas.com/inventor/takashi-hisamatsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 30(Granted Patents)


Location History:

  • Yokohama, JA (1978)
  • Yokohama, JP (1979 - 1981)

Company Filing History:

goldMedal5 out of 382 
 
Meiji Seika Kaisha, Ltd.
 patents
silverMedal2 out of 834,513 
Other
 patents

Years Active: 1978-1981

Loading Chart...
7 patents (USPTO):Explore Patents
1. 4283389 - Novel antibiotic, BN-183B substance (1981-08-11),
2. 4209509 - Substance SF-1739 derivatives, process for preparing the same and (1980-06-24),
3. 4202886 - Antibiotic SF-1942 substance and process for production of the same (1980-05-13),
4. 4180655 - Nitrosourea derivatives (1979-12-25),
5. 4160026 - Antibiotics SF-1130-x.sub.1 and -x.sub.2 substances and production and (1979-07-03),
6. 4151041 - Process for production of maltopentaose and maltohexaose (1979-04-24),
7. 4086415 - Nitrosourea derivatives of glycosides (1978-04-25),

Title: Takashi Hisamatsu: Innovator in Antibiotic Development

Introduction

Takashi Hisamatsu is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of antibiotic research, holding a total of 7 patents. His work focuses on developing novel substances that combat bacterial infections effectively.

Latest Patents

His latest patents include a novel antibiotic designated as BN-183B substance. This antibiotic is produced by cultivating a strain of the genus Pseudomonas and exhibits strong action against both Gram-positive and Gram-negative bacteria. Another notable patent involves Substance SF-1739 derivatives, which includes various forms such as Substance SF-1739 HP, Substance SF-1739 HP-C, Substance SF-1739 HP-F, Substance SF-1739 HP-3, and Substance SF-1739 HP-5. The physico-chemical properties of these derivatives are described in the specifications, along with processes for preparing them and antimicrobial compositions containing at least one of the said derivatives.

Career Highlights

Throughout his career, Takashi Hisamatsu has worked with Meiji Seika Kaisha, Ltd., where he has contributed to various research projects. His innovative approach to antibiotic development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

He has collaborated with notable coworkers such as Takashi Shomura and Michio Kojima, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Takashi Hisamatsu's contributions to antibiotic research and development have made a significant impact in the field. His innovative patents and collaborations highlight his dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…